[ad_1]
"SOn behalf of SUFU, we can not deny the fact that some patients have had problems with the mesh used for the repair of prolapse. This is a big problem. We're waiting for more data, but so far the FDA has taken a stand, and that's where we are.
If you ask me what is my biggest concern right now, it is the risk that slings will suffer the same fate as trellises for prolapse repair. Frankly, it would be a disservice to women since the literature on slings supports slings as a safe and effective option for the treatment of stress incontinence.
The SUFU strives to ensure that the slings are not grouped together with the prolapsed mesh and end up following the same path.
Lily: "Morbad Mesh" leaves the future in question
The slings were successful with a very low risk. The midurethral mesh tape has been studied more than any other anti-incontinence procedure and the literature is very favorable to the use of the strip as a safe and effective option.
If someone chooses to have no slingshot is good. We do not want women to lose the option to choose what the literature considers to be very viable, with a very good risk / benefit ratio.
The mesh for prolapse does not have as much documentation as the harness, so we would not want the prohibition of the use of the lattice on the prolapse is translated wrongly in the harness.
I hope that the sling is not affected, but the possibility is worrying given that it has been banned in other countries. This is what happened recently in the UK, even though they call it a "break", so let's hope it's only temporary. "
Kathleen Kobashi, MD
Society of urodynamics, female pelvic medicine and urobad reconstruction
Following: "The AAU understands the reasons for the FDA decision, which means that we must focus on using the patient's own tissue for badl repair."
Source link
